Organo Corporation (TYO:6368)
14,510
+180 (1.26%)
Feb 10, 2026, 3:30 PM JST
Organo Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 175,300 | 163,269 | 150,356 | 132,426 | 112,069 | 100,638 | |
Revenue Growth (YoY) | 9.69% | 8.59% | 13.54% | 18.16% | 11.36% | 4.27% |
Cost of Revenue | 111,725 | 108,087 | 106,514 | 97,449 | 83,556 | 74,311 |
Gross Profit | 63,575 | 55,182 | 43,842 | 34,977 | 28,513 | 26,327 |
Selling, General & Admin | 26,088 | 20,746 | 21,297 | 17,104 | 15,469 | 14,506 |
Research & Development | - | 3,253 | - | 2,615 | 2,146 | 2,300 |
Operating Expenses | 26,088 | 24,061 | 21,297 | 19,763 | 17,662 | 16,746 |
Operating Income | 37,487 | 31,121 | 22,545 | 15,214 | 10,851 | 9,581 |
Interest Expense | -262 | -246 | -240 | -159 | -127 | -117 |
Interest & Investment Income | 210 | 151 | 186 | 79 | 59 | 54 |
Earnings From Equity Investments | 134 | 122 | 203 | 208 | 160 | 153 |
Currency Exchange Gain (Loss) | 300 | 383 | 546 | 559 | 573 | 39 |
Other Non Operating Income (Expenses) | 78 | 107 | 186 | 118 | 121 | 189 |
EBT Excluding Unusual Items | 37,947 | 31,638 | 23,426 | 16,019 | 11,637 | 9,899 |
Gain (Loss) on Sale of Investments | 88 | 724 | 191 | 39 | 23 | -45 |
Gain (Loss) on Sale of Assets | 44 | 4 | 70 | 5 | 1,148 | 3 |
Asset Writedown | -9 | -9 | -55 | -28 | -113 | -161 |
Other Unusual Items | - | - | - | -1 | - | -2 |
Pretax Income | 38,070 | 32,357 | 23,632 | 16,034 | 12,695 | 9,694 |
Income Tax Expense | 9,869 | 8,171 | 6,298 | 4,270 | 3,470 | 2,608 |
Earnings From Continuing Operations | 28,201 | 24,186 | 17,334 | 11,764 | 9,225 | 7,086 |
Minority Interest in Earnings | -17 | -36 | -24 | -34 | -15 | -12 |
Net Income | 28,184 | 24,150 | 17,310 | 11,730 | 9,210 | 7,074 |
Net Income to Common | 28,184 | 24,150 | 17,310 | 11,730 | 9,210 | 7,074 |
Net Income Growth | 34.05% | 39.52% | 47.57% | 27.36% | 30.20% | -1.23% |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 | 46 |
Shares Change (YoY) | 0.02% | 0.09% | 0.14% | -0.07% | 0.03% | 0.26% |
EPS (Basic) | 613.06 | 525.37 | 376.92 | 255.76 | 200.67 | 154.18 |
EPS (Diluted) | 613.06 | 525.37 | 376.92 | 255.76 | 200.67 | 154.18 |
EPS Growth | 34.02% | 39.38% | 47.37% | 27.45% | 30.15% | -1.49% |
Free Cash Flow | - | 18,838 | - | -19,741 | 8,295 | -5,547 |
Free Cash Flow Per Share | - | 409.81 | - | -430.43 | 180.74 | -120.90 |
Dividend Per Share | 184.000 | 160.000 | 102.000 | 62.000 | 40.000 | 28.500 |
Dividend Growth | 39.39% | 56.86% | 64.52% | 55.00% | 40.35% | 9.62% |
Gross Margin | 36.27% | 33.80% | 29.16% | 26.41% | 25.44% | 26.16% |
Operating Margin | 21.38% | 19.06% | 14.99% | 11.49% | 9.68% | 9.52% |
Profit Margin | 16.08% | 14.79% | 11.51% | 8.86% | 8.22% | 7.03% |
Free Cash Flow Margin | - | 11.54% | - | -14.91% | 7.40% | -5.51% |
EBITDA | 39,348 | 33,046 | 24,555 | 17,038 | 12,183 | 10,793 |
EBITDA Margin | 22.45% | 20.24% | 16.33% | 12.87% | 10.87% | 10.72% |
D&A For EBITDA | 1,861 | 1,925 | 2,010 | 1,824 | 1,332 | 1,212 |
EBIT | 37,487 | 31,121 | 22,545 | 15,214 | 10,851 | 9,581 |
EBIT Margin | 21.38% | 19.06% | 14.99% | 11.49% | 9.68% | 9.52% |
Effective Tax Rate | 25.92% | 25.25% | 26.65% | 26.63% | 27.33% | 26.90% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.